Guidelines for lupus anticoagulant testing in South Africa
| dc.contributor.author | Bailly, J. | en_ZA |
| dc.contributor.author | Louw, S. | en_ZA |
| dc.contributor.author | De Koker, A. | en_ZA |
| dc.contributor.author | Potgieter, J. J. C. | en_ZA |
| dc.contributor.author | Coetzee, M. J. | en_ZA |
| dc.contributor.author | Chapanduka, Z. C. | en_ZA |
| dc.contributor.author | Opie, J. J. | en_ZA |
| dc.date.accessioned | 2020-09-21T07:55:16Z | |
| dc.date.available | 2020-09-21T07:55:16Z | |
| dc.date.issued | 2020 | |
| dc.description | CITATION: Bailly, J., et al. 2020. Guidelines for lupus anticoagulant testing in South Africa. Journal of Medical Laboratory Science and Technology of South Africa, 2(1):6-12, doi:The Journal of Medical Laboratory Science & Technology South Africa 2020; 2(1):6-12, doi:10.36303/JMLSTSA.2020.2.1.39. | |
| dc.description | The original publication is available at https://jmlstsa.smltsa.org.za | |
| dc.description.abstract | ENGLISH ABSTRACT: The lupus anticoagulant (LA) refers to the prolongation of certain coagulation tests due to the action of heterogenous autoantibodies. However, the LA is a misnomer since it is associated with thrombosis in vivo, and most commonly is detected as an incidental, transient laboratory finding associated with conditions such as autoimmune diseases, infections and even in healthy individuals. Repeatedly positive LA testing in the setting of thrombotic and/or obstetric complications is required to diagnose the antiphospholipid syndrome (APS). This review intends to provide clarity on LA testing in the South African context and to provide a national guideline in order to standardise LA testing, interpretation and reporting of results. | en_ZA |
| dc.description.uri | https://jmlstsa.smltsa.org.za/index.php/JMLSTSA | |
| dc.description.version | Publisher's version | |
| dc.format.extent | 7 pages : illustrations | en_ZA |
| dc.identifier.citation | Bailly, J., et al. 2020. Guidelines for lupus anticoagulant testing in South Africa. Journal of Medical Laboratory Science and Technology of South Africa, 2(1):6-12, doi:The Journal of Medical Laboratory Science & Technology South Africa 2020; 2(1):6-12, doi:10.36303/JMLSTSA.2020.2.1.39 | |
| dc.identifier.issn | 2708 3063 (online) | |
| dc.identifier.issn | 2664 2549 (print) | |
| dc.identifier.other | doi:10.36303/JMLSTSA.2020.2.1.39 | |
| dc.identifier.uri | http://hdl.handle.net/10019.1/108831 | |
| dc.language.iso | en_ZA | en_ZA |
| dc.publisher | The Society of Medical Laboratory Technologists of South Africa | en_ZA |
| dc.rights.holder | Authors retain copyright | en_ZA |
| dc.subject | Lupus -- Medical tests (Diagnosis) | en_ZA |
| dc.subject | Anticoagulants (Medicine) | en_ZA |
| dc.subject | Antiphospholipid syndrome | en_ZA |
| dc.subject | Diagnosis, Laboratory | en_ZA |
| dc.title | Guidelines for lupus anticoagulant testing in South Africa | en_ZA |
| dc.type | Article | en_ZA |